Female Transitions - Park County Chiropractic
Transcription
Female Transitions - Park County Chiropractic
Your Agenda General Female health Premenstrual syndrome Depression When things go wrong Dysmenorrhea Polycystic ovarian syndrome Heavy Metal issues, fertility and bone health Menopause Female Transitions Lee W Carroll B.Sc. 2 Female Vitality/Health/Wellness Female Vitality/Health/Wellness Liver Detoxification of estrogens and xenoestrogens Gut Activation of phytoestrogens Prevent recycling of estrogens Upper reproductive tract Support healthy functioning of ovaries, fallopian tubes and uterus Reduce spasm and cramping Muscle Support energy metabolism Stress Adaptive stress response Harmonization of the HPA axis Cellular stress response Hormonal balance Prolactin/Dopamine Estrogen Progesterone Androgens 3 © Lee Carroll 2012 4 1 White Peony White Peony Indications Paeonia lactiflora peeled root is very commonly used in traditional Chinese medicine (TCM) to treat a wide range of gynecological problems, often in combination with other herbs Reduces elevated androgens Improves low progesterone Reduces elevated prolactin Modulates estrogen (high or low) PMS and Mastalgia Hyperprolactinemia Dysmenorrhoea Amenorrhoea PCOS Endometriosis Fibroids Ovulatory failure Infertility Androgen excess Menopause Pain and spasm of the abdomen and limbs Cognitive impairment 5 Shatavari – 100 Husbands Schisandra – Five Flavors When translated, Shatavari literally means: Schisandra chinensis fruit has a long history of use in traditional Chinese and Japanese medicine Hepatoprotective Induces Phase I enzymes Increases Phase II enzymes Hepatic glutathione reductase Glutathione-S-transferase (GST) Antioxidant Facilitates adaptation to stress Nervous system tonic “She who possesses a hundred husbands” Considered both a general tonic and a female reproductive tonic Promote general well being by increasing cellular vitality and resistance to stress Promote estrogen production and balance Relief of menopausal symptoms To improve libido and sexual vitality As a tonic for general debility, fatigue, infections Liver support/gastric ulcers and dyspepsia © Lee Carroll 2012 6 7 8 2 FemCo Schisandra Indications To enhance phase I/II detoxification by the liver Chronic liver damage Fatigue/Physical stress/debility To improve physical and mental performance and concentration Schisandra fruit extract 6:1 from Schisandra chinensis fruit 1.0 g 166.6 mg White Peony root extract 4:1 from Paeonia lactiflora root 750 mg 187.5 mg Shatavari root extract 6:1 100 mg from Asparagus racemosus root 600 mg Suggested use: 1 tablet 3 to 4 times daily Contraindicated in pregnancy 9 FemCo Key Applications FemCo Key Indications Adjunctive treatment: Anemia Androgen excess and polycystic ovary syndrome Reduced fertility and low libido Conditions of estrogen excess such as endometriosis and fibroids Everyday female support To promote, health, vitality and wellness from adolescence to menopause and beyond Specific female stress support Liver Support Premenstrual syndrome Irregular menstruation Dysmenorrhoea 11 © Lee Carroll 2012 10 12 3 FemCo Additional Indications How to Use FemCo Any conditions associated with elevated prolactin Delayed puberty Leg Cramps Migraine headache To improve memory and concentration To improve physical ad exercise performance Night sweats Everyday for female health, vitality, wellness FemCo becomes the foundational MediHerb product for the premenopausal female Female general health protocol example FemCo, 3 tablets per day Catalyn, 6 tablets per day Symplex F, 3 tablets per day 13 14 General Fertility Protocol General Estrogen Dominance FemCo, 3 to 4 tablets per day Chaste tree, 1 to 2 tablets per day Tribulus, 2 tablets 2 times per day from day 5 to 14 of the menstrual cycle Wheat Germ Oil, 6 perles per day Symplex F, 6 tablets per day 15 © Lee Carroll 2012 FemCo, 3 to 4 tablets per day Chaste Tree, 1 to 2 tablets per day Silymarin, 1 tablet per day Cruciferous Complete, 3 capsules 2 times per day 16 4 Premenstrual Syndrome (PMS) General Androgen Excess PMS – is a variety of psychological, behavioral and physical symptoms that collectively occur during the luteal phase of the menstrual cycle and subside with the onset of the period or soon after PMDD – Premenstrual dysphoric disorder Premenstrual magnification of a pre-existing condition, eg headaches, depression and anxiety increased infection rates, IBS and hypoglycemia FemCo, 3 to 4 tablets per day Chaste tree, 2 tablets 2 to 3 times per day Adrenal Complex, 2 to 3 tablets per day Symplex F, 6 tablets per day Ovex, 6 tablets per day 17 PMS – Essential Issues Exact cause is unknown but in 50% of women ovarian suppression removes symptoms Hormonal, dietary, lifestyle, emotional factors are collectively implicated “Abnormal responses to normal hormones” 19 © Lee Carroll 2012 18 Serotonin GABA (gamma-amniobutyric acid) Melatonin Endorphins Estrogen/progesterone balance Progesterone receptors Allopregnanolone Adrenal hormones Prolactin/Dopamine Nutrients: Vitamin B6, E and D, Ca, Mg, Omega-3 essential fatty acids, chromium, copper, manganese 20 5 Chaste Tree Categories of PMS Symptoms PMS with mood changes Chaste tree (Vitex agnus castus) is a Western herb with a long history of use for hormonal and gynecological problems Type A: anxiety, nervous tension, irritability, anger Type B: depression, sadness, withdrawal, fatigue Chaste Tree is dopaminergic, specifically decreasing excess prolactin This has particular relevance for women with latent hyperprolactinaemia (LHP) where prolactin is only increased with stress and/or premenstrually PMS with cravings PMS with fluid retention PMS with pain PMS with declining estrogen PMS with adrenal exhaustion 21 Chaste Tree: The Research A systematic review of herbal treatments for PMS found that Chaste Tree was the most investigated treatment and, after excluding trials because of poor quality or unsuitable diagnostic criteria, identified 4 eligible trials involving 500 women1 The review concluded that Chaste Tree was useful for PMS Several other trials showing benefit in premenstrual mastalgia have also been published, including one that demonstrated it lowered prolactin levels 1 Dante G, Facchinetti F. J Psychosom Obstet Gynaecol 2011; 32(1): 42-51 22 Chaste Tree - Prolactin Frequent blood samples were taken from patients with premenstrual mastalgia (and presumably LHP) As a result of the stress of blood withdrawal prolactin levels in the pathological range were observed There were also pathological surges of prolactin associated with LH pulses After 3 months of a Chaste Tree formulation these responses were not evident Wuttke W, Jarry H, Christoffel V et al. Chaste tree (Vitex agnus-castus) – pharmacology and clinical indications. Phytomedicine 2003; 10: 348-357 24 © Lee Carroll 2012 6 Chaste Tree and Melatonin Chaste Tree According to Dioscorides (De Materia Medica AD40 to 80) when writing about Chaste Tree: “A weight of 1 drachma in wine makes the menses come on earlier, detaches the embryo, attracts the milk, goes to your head and brings sleep.” Chaste Tree is most indicated in PMS with mood changes, anxiety, depression and fluid retention Chaste Tree tablets 1 to 2 per day Upton R, Petrone C, Graff A. (eds) Chaste Tree Fruit: Vitex agnus-castus, American Herbal Pharmacopoeia and Therapeutic Compendium, American Herbal Pharmacopoeia, Santa Cruz, CA, 2001. 25 Chaste Tree and Melatonin The circadian rhythm of melatonin secretion was measured in 20 healthy males aged 20 to 32 years after the intake of placebo or various doses of an extract of Chaste Tree (up to 480 mg/day) for 14 days in an open, placebo-controlled study Administration of Chaste Tree caused a dose-dependent increase of melatonin secretion (average 60%), especially during the night (compared to placebo treatment) Dericks-Tan JS, Schwinn P, Hildt C. Exp Clin Endocrinol Diabetes 2003; 111(1): 44-46 St. John’s Wort and PMS An analysis of 15 clinical trials suggested a role for antidepressant drugs in PMS, especially Prozac, but there were side effects Results of an open pilot trial of St. John’s Wort in PMS yielded positive results Improvement in overall PMS scores was 51% with two-thirds experiencing at least a 50% reduction in symptom severity Stevinson C, Ernst E. ‘A pilot study of Hypericum perforatum for the treatment of premenstrual syndrome’, BJOG 2000; 107(7): 870-876 28 © Lee Carroll 2012 7 St. John’s Wort and PMS Evening Primrose Oil St John’s Wort is most indicated in PMS with mood and depression St. John’s Wort 1.8g tablets, 1 to 3 per day Or Nevaton tablets, 3 to 4 per day The clinical relevance of Evening Primrose Oil use in PMS has been questioned however a recent 2010 clinical study shows EPO is of particular value for mild to moderate premenstrual mastalgia at 1g per day, when used over 3 to 6 months EPO is also indicated in PMS with pain Required dose is 3-6g per day N. Thakur, B. Zargar, N. Nazeer, F. Parray & R. Wani : Mastalgia – Use Of Evening Primrose Oil In Treatment Of Mastalgia. The Internet Journal of Surgery. 2010 Volume 24 Number 2 29 Ginkgo A French study found that Ginkgo biloba extract was effective against congestive symptoms Design was a placebo-controlled trial involving 165 women with PMS. Ginkgo dose was 160 mg per day Significant improvements with Ginkgo treatment over placebo was observed for mastalgia as well as edema, anxiety, depression and headache 30 Ginkgo Ginkgo biloba extract reduced severity of physical and psychologic PMS symptoms (24%) compared to placebo (9%) (p < 0.001) Dose was equiv. to Ginkgo Forte, 2 tablets per day from day 16 of the menstrual cycle to day 5 of the following cycle Ozgoli G, Selselei EA, Mojab F, Majd HA, A randomized, placebo-controlled trial of Ginkgo biloba L. in treatment of premenstrual syndrome. J Altern Complement Med. 2009 Aug;15(8):845-51. Tamborini A, Taurelle R. ‘[Value of standardized Ginkgo biloba extract (EGb 761) in the management of congestive symptoms of premenstrual syndrome]’, Revue Francaise de Gynecologie et d’Obstetrique 1993; 88(7-9): 447-457 32 © Lee Carroll 2012 8 PMS – Core Treatment PMS with Mood Changes Mood changes, anxiety and depression Core Support Nevaton or St John’s Wort 1.8g, 3 to 4 tablets/day And select as appropriate Valerian Complex tablets (3 to 4 per day) if excessive anxiety Rhodiola & Ginseng Complex tablets (2 to 4 per day) if depletion and depression Drenamin, 6 to 9 per day Min-Chex 6 per day Mood swings, fatigue, breast fullness, abdominal bloating Chaste Tree, 1 to 2 tablets per day FemCo, 3 to 4 tablets per day Symplex F, 3 tablets per day B6 Niacinamide, 4 to 6 per day Taken throughout the cycle for at least 3 months 33 PMS with Cravings PMS with Fluid Retention Cravings, increased appetite, fatigue, Irritability FemCo, 3 to 4 tablets per day Symplex F, 3 tablets per day And select as appropriate Gymnema 4g, 2 to 3 tablets per day Diaplex, 3 to 9 capsules per day Cataplex GTF, 3 to 6 tablets per day Magnesium Lactate 3 to 6 capsules per day Whey Pro Complete Breast fullness, weight gain, swollen extremities, abdominal bloating Core Support And select as appropriate Gingko Forte 3 tablets each per day from day 16 of cycle to day 5 of following cycle Dandelion Leaves 1:1, 5 mL 2 to 3 times per day from day 16 of cycle to day 5 of following cycle Evening Primrose Oil, 3 to 6 capsules per day AC Carbamide, 4 capsules per day 35 © Lee Carroll 2012 34 36 9 PMS with Pain PMS with Low Estrogen Breast pain, dysmenorrhea, reduced pain threshold, general aches and pains Core support And select as appropriate Cramplex, 2 tablets 2 to 4 times per day from late in the luteal phase to day 4 or 5 of cycle Evening Primrose Oil, 3 to 6 capsules per day Chlorophyll Complex, 4 to 6 perles per day Calcium Lactate, 3 to 6 capsules or ½ tablespoon three times per day Fatigue, memory, hot flashes, night sweats, headaches Core Support Wild Yam Complex, 3 to 4 tablets per day Or Tribulus Forte, 3 tablets per day And select as appropriate Bone Complex, 3 tablets per day Nevaton, 3 to 4 tablets per day Ovex, 3 to 6 tablets per day Wheat Germ Oil, 6 perles per day 37 PMS with Adrenal Exhaustion PMS Case History Fatigue, mental fatigue, poor concentration, hot flashes and night sweats Core Support And select as appropriate Adrenal Complex, 2 to 3 tablets per day Rhodiola & Ginseng Complex 2 to 4 tablets per day Drenamin, 3 tablets 2 times per day A 34 year old woman with a 3 year old child presented with severe PMS which regularly began 6 to 7 days before the onset of menstruation and persisted until the first day of bleeding Symptoms were severe depression, irritability, anxiety, poor sleep, fluid retention and breast tenderness Questioning revealed a history of liver problems and increased levels of stress and devitalization caused by not coping with the responsibility of caring for her young child 39 © Lee Carroll 2012 38 40 10 PMS Case History PMS Case History Treatment consisted of: Chaste Tree, 1 tablet 2 times per day FemCo, 3 tablets per day Valerian Complex, 2 tablets with evening meal and 2 tablets at bed time Silymarin, 1 tablet per day Withania Complex, 3 tablets per day (1 tablet am and 2 tablets at bed time After four weeks there was a mild improvement but all symptoms still present. Over the next two months on the same treatment there was steady improvement. The breast and fluid symptoms were totally gone and the emotional symptoms and energy levels were considerably better. Treatment was continued and at 4 months all the symptoms were virtually gone. The treatment was reduced to only Chaste Tree, with Valerian Complex symptomatically and the patient has remained virtually symptom-free 41 42 Depression and Female Health Depression and BMD The association between clinical depression & low bone mineral density (BMD) is not new! In one well designed study depressed patients had 6.5% lower BMD at the spine & 13.6% lower BMD at the femoral neck compared to non-depressed controls What is new! Stronger effects in premenopausal women Major depression in premenopausal women is a risk factor for significantly low BMD Meta-analysis of 23 studies comparing 2327 depressed with 21,141 non-depressed individuals. Also increased urinary levels of bone resorption markers Michelson D, Stratakis C, Hill L et al. Bone mineral density in women with depression. N Engl J Med 1996; 335(16): 1176-1181 Yirmiya R, Bab I. Major depression is a risk factor for low bone mineral density: a meta-analysis. Biol Psychiatry. 2009 Sep 1;66(5):423-32. Epub 2009 May 15 43 © Lee Carroll 2012 44 11 Depression and Cortisol Neural Regulation of Bone Plasma cortisol levels were significantly higher in depressive patients (p = 0.001) Lumbar and femur BMD scores were negatively correlated with cortisol levels in the patient group BMD was significantly lower at the lumbar spine and proximal femur (p = 0.02, 0.01). Osteocalcin ↓ and C-telopeptide ↓ 36 premenopausal women with major depression compared with 41 controls There is a growing body of evidence demonstrating the potential for the neural regulation of bone Providing increasing evidence that 5-HT (serotonin) & 5-HTT (serotonin transporter) have a role within the skeleton Functional pathways to respond to & uptake 5-HT have been indentified in osteoblasts, osteoclasts & osteocytes Altindag O, etal, Relation of cortisol levels and bone mineral density among premenopausal women with major depression, Int J Clin Pract. 2007 Mar;61(3):41620 Haney EM, Warden SJ. Skeletal effects of serotonin transporter inhibition: Evidence from clinical studies. J Musculoskelet Neuronal Interact 2008; 8(2): 133-145 45 46 Serotonin: The Gut & Bone SSRIs Experimental research has shown that gut serotonin can directly control bone formation by inhibiting osteoblast proliferation If more gut derived serotonin reaches the bone, the more bone is lost And conversely the less serotonin, the denser & stronger bones become 5-HT is unique among the neurotransmitters because of its link with depression 5-HTT antagonists (SSRIs) are the mainstay of the medical treatment for depression The widespread use of SSRIs provides the epidemiological platform for the effects of serotonin on bone Haney EM, Warden SJ. Skeletal effects of serotonin transporter inhibition: Evidence from clinical studies. J Musculoskelet Neuronal Interact 2008; 8(2): 133-145 Yadav VK, Ryu JH, Suda N et al. Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell 2008; 135(5): 795-796 47 © Lee Carroll 2012 48 12 SSRIs and BMD SSRIs and BMD SSRIs are linked with bone density loss A study of BMD in 2,722 women with an average age of 78.5 years (follow up at 4.9 years) 198 had used SSRIs for depression SSRIs - BMD decrease 0.82% (higher at hip) TCAs and non-SSRI users - BMD 0.47% Prospective population-based cohort study consisting of 7983 individuals aged 55 years & older The use of TCA and SSRIs resulted in a 2.35 fold increased risk of nonvertebral fractures compared to non-users of antidepressants Risk of fracture increases with prolonged use of SSRIs Ziere G, Dieleman JP, van der Cammen TJ et al. Selective serotonin reuptake inhibiting antidepressants are associated with an increased risk of nonvertebral fractures. J Clin Psychopharmacol 2008; 28(4): 411-417 Diem SJ, Blackwell TL, Stone KL et al. Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures. Arch Intern Med 2007; 167(12): 1240-1245 49 50 51 52 St John’s Wort Meta-Analysis St John’s Wort extract is superior to placebo in patients with major depression Treatment responses in St John’s Wort and antidepressant groups were almost identical St John’s Wort group reported significantly less side effects A total of 29 trials and 5489 patients Linde K, Berner MM, Kriston L. Cochrane Database Syst Rev 2008;(4): CD000448 © Lee Carroll 2012 13 Rhodiola and Depression Support for Depression Rhodiola is anti-depressive in patients with mild to moderate depression at 340 and 680 mg/day over a 6week period Depression, insomnia, emotional instability and somatization, improved significantly following treatment At 680 mg/day self esteem increased significantly Energy levels ↑ Down-regulation of stress activated intracellular pathways and up-regulation of Hsp70 Rhodiola & Ginseng Complex, 1 tablet 2-4 times daily St John’s Wort 1.8g, 1 tablet 3 times daily Or Nevaton, 1 tablet 3-4 times daily Adrenal Complex, 1 tablet 2-3 times daily Symplex F 6 per day Min-Chex 6 per day Darbinyan V et al. Nord J Psychiatry 2007; 61(15): 343-348 54 53 Ginkgo: Mood and Stress Ginkgo: Mood and Stress Decreased anxiety in patients with defined anxiety disorders (240 mg/day std extract)1 Had a beneficial effect on sleep patterns in patients with major depression being treated with trimipramine (240 mg/day std extract)2 Addition of Ginkgo to paroxetine (SSRI) provided better therapeutic effect than paroxetine alone in patients with depression3 Ginkgo extract at 120 mg/day for 3 months significantly dropped plasma cortisol levels during the stress caused by the glucose tolerance test in healthy volunteers1 According to the scientists involved in the trial, Ginkgo might reduce blood levels of cortisol in other types of stress 1. Woelk H et al. J Psychiatr Res 2007; 41(6): 472-480 2. Hemmeter U et al. Pharmacopsychiatry 2001; 34(2): 50-59 1. Kudolo GB. Clin Chem 2007; 53(6, Suppl S): A186 3. Guo KF et al. Chin J Clin Rehab 2006; 10(2): 43-45 Cited in – MediHerb A Phototherapist’s Perspective 2009; 123 55 © Lee Carroll 2012 56 14 Ginkgo: Sexual Dysfunction Ginkgo Forte Ginkgo was found to be very effective in the treatment of antidepressant-induced sexual dysfunction, predominantly caused by SSRIs Women were more responsive to the sexual enhancing effects of Ginkgo than men with success rates of 91% (women) versus 76% men Ginkgo had a positive effect on all 4 phases of the sexual response cycle: desire, excitement, orgasm, resolution Ginkgo leaf 50:1 extract from Ginkgo biloba leaf 3.0 g Containing ginkgo flavonglycosides 14.4 mg Containing ginkgolides & bilobalide 3.6 mg 60 mg Dose: 1 tablet 2 to 4 times daily Cohen AJ et al. J Sex Marital Ther 1998; 24(2): 139-143 57 58 .. Diseases Linked to Dysbiosis Crohn’s disease Ulcerative colitis Rheumatoid arthritis Ankylosing spondylitis Graves disease Chronic active hepatitis Guarner F. Digestion 2006; 73 (Suppl 1): 5-12 © Lee Carroll 2012 15 Diseases Linked to Dysbiosis Gut Disorders Irritable bowel syndrome (IBS) Flatulent dyspepsia Certain types of food sensitivities Chronic diarrhoea and constipation Diverticular disease Gastrointestinal infections and intestinal overgrowth eg candida Diseases Linked to Dysbiosis Other Disorders Allergies such as asthma and hay fever Poor immunity Chronic skin disorders Breast and colon cancer Insulin resistance and diabetes Lack of well-being, low energy and poor digestion Neuropsychiatric problems especially autism? Obesity? Hypertension? Depression? Gut Flora Complex Anise (Pimpinella anisum) fruit ess. oil General Estrogen Dominance 125 mg Oregano (Origanum vulgare) leaf ess. oil 75 mg Andrographis herb 10:1 extract from Andrographis paniculata herb 1.0 g Containing andrographolide 10 mg 100 mg Phellodendron stem bark 20:1 extract from Phellodendron amurense stem bark 1.6 g Containing berberine 36 mg 80 mg FemCo, 3 to 4 tablets per day Chaste Tree, 1 to 2 tablets per day Silymarin, 1 tablet per day Cruciferous Complete, 3 capsules 2 times per day Symplex F, 3 to 6 tablets per day Bowel Flora Protocol for 6 to 10 weeks Suggested Dosage: 3-6 capsules per day 64 © Lee Carroll 2012 16 Simplified Bowel Flora Protocol When Things Go Wrong! Everyday of the Week Gut Flora Complex, 1 capsule 2 twice daily Wholefood Fibre, 1 tablespoon twice daily at the same time as the Gut Flora Complex As required: Vitanox, 2 to 3 tablets daily ProSynbiotic, 3 capsules daily Lactic Acid Yeast, 1 to 2 wafers 3 times daily Continue for minimum of 6 weeks. Suitable for long term use Dysmenorrhea Menorrhagia (see appendix) Amenorrhea and oligomenorrhea (see appendix) Endometriosis (see appendix) Polycystic ovarian syndrome 65 66 The Usual Suspects Dysmenorrhea Diet/long term dietary restrictions/nutrient status Exercise/sedentary lifestyles/over exercise Body weight/obesity/abnormally low body weight Stress Mood Sleep Alcohol/Tobacco/Recreational drugs Environmental toxins Essential Features Dysmenorrhea is painful or difficult menstruation It is associated with a number of factors including the production of inflammatory prostaglandins, vasoconstriction in small arteries, ischemia, and high cervical tone Dysmenorrhea affects 92% of American women It may be associated with other disorders such as endometriosis and pelvic infection 67 © Lee Carroll 2012 68 17 Dysmenorrhea Support Dysmenorrhea Core Support Cramplex, 2 tablets every 4 hours, 3 to 4 times a day Best to start a few days before menstruation Eases pain, reduces inflammation and uterine spasm Stimulates circulation and assists with hormonal balance Has antiemetic properties Pain starts a few hours before or at the onset of menstruation and often ceases within 24 hours Pain is largely due to uterine spasm and resultant ischemia due to excessive release of prostaglandins Aims of treatment Normalize the activity of the uterine muscle Regulate hormone levels Relieve pain 69 Dysmenorrhea Support Cramplex Each tablet contains: Corydalis tuber 5:1 extract from Corydalis ambigua tuber 1.2 g Raspberry Leaf 4:1 extract from Rubus idaeus leaf 800 mg Wild Yam root and rhizome 4:1 extract from Dioscorea villosa root and rhizome 800 mg Cramp Bark stem bark 5:1 extract from Viburnum opulus stem bark 800 mg Ginger rhizome 6:1 extract from Zingiber officinale rhizome 800 mg Dosage: 2 tablets every 4 hours, 3 to 4 times a Best to start a few days before menstruation © Lee Carroll 2012 70 240 mg 200 mg 200 mg 160 mg 133.3 mg day. FemCo: 1 tablets 3 to 2 times daily throughout cycle Reduces uterine spasm, aids in the liver processing hormones, assists with hormone balance Ginkgo Forte, 2 to 3 tablets per day before the period is due to start and for several days into the period Improves circulation, which is of benefit in dysmenorrhea when vasoconstriction in small arteries and ischemia occurs Dong Quai, 1 tablet 2 to 3 times daily Used traditionally for dysmenorrhea Ovex P, 6 tablets per day Utrophin, 4 to 6 tablets per day 72 18 Polycystic Ovarian Syndrome Polycystic Ovarian Syndrome Common characteristic features include obesity, insulin resistance, hyperandrogenism, anovulation and acne Approximately 50% of women with PCOS are overweight or obese1 In the US up to 50% of women with PCOS have metabolic syndrome. Hyperandrogenism was present in 87% of women with PCOS2 Polycystic ovarian syndrome (PCOS) is a common reproductive disorder resulting in anovulation and amenorrhoea for many women It occurs in approximately 5-10% of women of reproductive age1 and is the most common endocrine disorder causing female infertility2 Not all women with PCOS have polycystic ovaries 1. 2. Boomsma CM, Eijkemans MJC et al. Hum Reprod Update 2006; 12(6): 673-683 Shroff R, Syrop C et al. Fertil Steril 2007; 88(5): 1389-1395 73 Biochemical and Clinical Features Herbal Treatment for PCOS When the patient is overweight or obese the number one goal of treatment must be weight loss, especially from the abdomen Treat metabolic disturbances eg dysglycemia, insulin resistance Treat hormonal disturbances Where applicable treat disturbance in liver function and serum lipids Increased serum androgen (testosterone, androstenedione, DHEAS)1 with or without hyperinsulinaemia Decreased SHBG levels1 Increased LH levels and serum LH to FSH ratio > 21 Increased prolactin levels1 Increased estrone levels. Estradiol can be increased, but is typically low or normal2 Increased fasting insulin or fasting glucose1 1. Harwood K Vuguin P et al. Horm Res 2007; 68(5): 209-217 2. Vignesh JP, Mohan V. J Postgrad Med 2007; 53(2): 128-134 75 © Lee Carroll 2012 74 76 19 Protocol for PCOS Protocol for PCOS Core Support Gymnema 4g: 1 tablet 2 to 3 times daily Normalise glucose metabolism, reduce insulin resistance, reduce sugar cravings Chaste Tree: 2 tablets 2 to 3 times daily Reduce hyperprolactinaemia FemCo: 2 tablets 2 times daily Reduces elevated LH, reduces elevated prolactin Symplex F: 3 to 6 tablets per day Prolamine Iodine: 1 to 2 tablets per day Core Support Adrenal Complex: 1 tablet 2 to 3 times daily Licorice inhibits 11 beta-hydroxysteroid dehydrogenase Type 1 which reduces the production of cortisol in abdominal adipocytes and causes fat loss White Peony (FemCo) and Licorice decreased serum free testosterone by increasing ovarian aromatase activity Significantly lowered LH/FSH ratio Decreased prolactin levels in anovulatory women with elevated serum prolactin 77 Protocol for PCOS Protocol for PCOS Core Support for Fertility Tribulus 1 tablet 3 times daily on days 5 to 14 of the menstrual cycle (or to ovulation) if menstruating or 1 tablet 3 times daily every day if non-menstruating Additional Support Coleus Forte: 1 tablet 3 times daily Improve weight loss, burn fat and build lean body mass Silymarin: 1 tablet 2-3 times daily Improve glycemic profile, reduce insulin resistance, enhance liver function 79 © Lee Carroll 2012 78 80 20 Heavy Metal Exposure and Repeated Miscarriages Heavy Metal Exposure and Repeated Miscarriages Heavy metal excretion was significantly correlated to different immune and hormonal phenomena The authors concluded that heavy metals appear to have a negative impact on ovarian and pituitary function and that the induced immunological changes may lead to miscarriages 111 women with repeated miscarriages had their urinary excretion of heavy metals evaluated after challenge (with a chelating drug) Basal Levels 180 min Challenge Arsenic 4.80 µ/dL 15.3 µ/dL Cadmium 0.52 0.84 Mercury Lead 5.40 3.90 97.14 41.73 Gerhard I, Waibel S, Daniel V et al. Impact of heavy metals on hormonal and immunological factors in women with repeated miscarriages. Hum Repro Update 1998; 4(3): 301-309 Gerhard I, Waibel S, Daniel V et al. Impact of heavy metals on hormonal and immunological factors in women with repeated miscarriages. Hum Repro Update 1998; 4(3): 301-309 81 Mercury Excretion and Amalgam Heavy Metal in Living Kidney Cortex Urinary mercury excretion (ug/g creatinine) 180 160 82 Metal concentrations were determined in 109 living Swedish kidney donors aged 24-70 years Median kidney concentrations were: 12.9 mcg/g for cadmium 0.21 mcg/g for mercury 0.08 mcg/g for lead H g b asal H g 120’ H g 180’ 140 120 100 80 60 40 Barregard L, etal, Cadmium, mercury, and lead in kidney cortex of living kidney donors: Impact of different exposure sources. Environ Res. 2010 Jan;110(1):4754. 20 0 1 -5 6 -1 0 >10 N u m b e r o f a m a lg a m to o th fillin g s Urinary Hg excretion vs no. of amalgam fillings, before and after challenge © Lee Carroll 2012 83 84 21 Cadmium Heavy Metal in Living Kidney Cortex Cadmium increased by 3.9 mcg/g for a 10 year increase in age Low iron stores (low serum ferritin) in women increased kidney cadmium by 4.5 mcg/g Kidney mercury increased by 6% for every additional amalgam surface Dental amalgam is the main determinant of kidney mercury Cadmium accumulates in the body, particularly the kidney. Half-life 10-30 years Women generally accumulate more than men Urinary Cd (U-Cd) is a biomarker for lifetime Cd body burden in people with lower exposures In the absence of high-level exposure, Cd-binding sites are not saturated, and the urine Cd level increases in proportion to the amount of Cd stored in the body Barregard L, etal, Cadmium, mercury, and lead in kidney cortex of living kidney donors: Impact of different exposure sources. Environ Res. 2010 Jan;110(1):47-54 Centers for Disease Control and Prevention (CDC) 2005; IPCS 1992 Agency for Toxic Substances and Disease Registry (ATSDR) 1999 85 Cadmium Cd - A Potent Metallohormone FDA Total Diet Study showed Cd exposure in the US increased 21% from 1990 to 2003 From 8.81 to 11.06 μg/person/day 11.06 μg/person/day exposure is approximately 17% of the WHOs PTWI of 7 μg/kg/week OSHA minimum safety standard for Cd is: < 3 μg/g in urine (as creatinine) < 5 μg/L in blood At doses similar to the WHO PTWI, Cd mimics the in vivo effects of estrogen Strong evidence exposure to environmentally relevant doses of cadmium may increase the risk of breast and endometrial cancer Prostate cancer (metalloandrogen) Adversely effects the lung, liver, immune system and bone Bryne C, etal, Cadmium - A metallohormone?, Toxicol Appl Pharmacol. 2009 Aug 1;238(3):26671. Epub 2009 Apr 9 Egan SK, Bolger PM, Carrington CD, Update of US FDA's Total Diet Study food list and diet, I. 2007 Sep;17(6):573-82. Epub 2007 Apr 4 87 © Lee Carroll 2012 86 88 22 Cadmium Population Study Cadmium Population Study OSHA minimum safety standard is 3 μg/g NHANES data, 4,258 U.S. women >50 Yrs from MA Risk of having hip-BMD-defined osteoporosis (OP) was correlated with urinary Cd levels Women with U-Cd b/w 0.50 & 1.0 μg/g had 43% increased risk compared to women with levels < 0.50 μg/g Smokers did not show a statistically increased risk U.S. women are at risk of developing OP at U-Cd levels 3 to 6 times less than the OSHA min safety std 21% of OP prevalence among women > 50 years of age may be attributable to Cd body burden Gallagher CM, John S. Kovach JS, and Meliker JR, Urinary Cadmium and Osteoporosis in U.S. Women ≥ 50 Years of Age: NHANES 1988–1994 and 1999–2004, Environmental Health Perspectives, Vol 116, 10, Oct 2008 pp. 1338-43 Gallagher CM, John S. Kovach JS, and Meliker JR, Urinary Cadmium and Osteoporosis in U.S. Women ≥ 50 Years of Age: NHANES 1988–1994 and 1999–2004, Environmental Health Perspectives, Vol 116, 10, Oct 2008 pp. 1338-43 89 Cadmium Swedish Study Cadmium Swedish Study Cadmium related effects on bone in 820 women (53-64 years of age) U-Cd was 0.67 μg/g creatinine Bone mineral density, parathyroid hormone, and urinary deoxypyridinoline (U-DPD) were adversely associated with U-Cd (p < 0.05) in all subjects Smokers did not show a statistically increased risk For U-DPD, there was a significant interaction between cadmium and menopause (p = 0.022) Low-level cadmium exposure: Has negative effects on bone Increases bone resorption Intensifies bone loss after menopause Akesson A, etal, Cadmium-induced effects on bone in a population-based study of women. Environ Health Perspect. 2006 Jun;114(6):830-4. Akesson A, etal, Cadmium-induced effects on bone in a population-based study of women. Environ Health Perspect. 2006 Jun;114(6):830-4. 91 © Lee Carroll 2012 90 92 23 ChelaCo Cadmium Swedish Study Also looked at Lead (Pb) Pb accumulates in bone by replacement of Ca The skeleton contains as much as 90% of the lead body burden Bone markers showed clear associations with blood lead ↑ Blood lead = ↑ Bone Resorption Akesson A, etal, Cadmium-induced effects on bone in a population-based study of women. Environ Health Perspect. 2006 Jun;114(6):830-4. Garlic bulb powder from Allium sativum bulb 100 mg Containing alliin 2.0 mg 100 mg Hawthorn flowering tops extract 3:1 from Crataegus monogyna flowering tops 300 mg 100 mg Milk Thistle seed extract 70:1 from Silybum marianum seed dry 7.0 g Containing flavanolignans as silybin 80 mg 100 mg Dose: 1 enteric coated tablet, 3 times daily with meals 93 Primary Indication Environmental exposure to heavy metals Suggested Use Preventing / minimizing the gastrointestinal absorption of environmental metals Promoting the excretion of metals from the body Antioxidant In anemia and cases where iron supplementation is required, do not take simultaneously with meals to iron supplements Heavy Metal Support Core Support ChelaCo, 1 tablet 3 times daily or Garlic 5000mg, 1 tablet 2 to 3 times daily And Parotid PMG, 2 tablets 3 times daily Zinc Liver Chelate, 1 tablet 3 times daily Cholacol II, 4 tablets twice daily on an empty stomach 95 © Lee Carroll 2012 94 96 24 Zinc and Bone Onions and Bone Density Zinc (Zn) is an important mineral required for normal bone development Bone Zn content has been shown to decrease in aging, with skeletal unloading and postmenopausal conditions Zn has a stimulatory effect on osteoblastic bone formation and mineralization and it stimulates cellular protein synthesis More NHANES data 2003 - 2004 Onion consumption has a beneficial effect on bone density in peri and post menopausal non-Hispanic white women 50 years and older Participants were divided into: Onions less than once a month Twice a month to twice a week Three to six times a week Once a day or more Yamaguchi M. Role of nutritional zinc in the prevention of osteoporosis. Mol Cell Biochem. 2009 Dec 25. [Epub ahead of print] 97 98 The Menopausal Change Onions and Bone Density Bone density increased as the frequency of onion consumption increased Individuals who consumed onions once a day or more had an overall bone density that was 5% greater than individuals who consumed onions once a month or less (P < 0.03) Older women who consume onions most frequently may decrease their risk of hip fracture by more than 20% versus those who never consume onions Not all women experience menopausal symptoms About 70% experience hot flashes and 40% suffer from depression Other symptoms such as sweating, fatigue, irregular menstruation and insomnia occur in 20-40% of perimenopausal women Matheson EM, etal Assoc b/w onion consumption and bone density in peri & post menopausal white women ≥50 years. Menopause 2009 Jul-Aug;16(4):756-9 99 © Lee Carroll 2012 100 25 The Menopausal Change The Menopausal Change The aims of herbal treatments are to: assist the adjustment to this important change provide symptomatic alleviation of the effects of estrogen withdrawal During the transitional years, hormone levels can fluctuate wildly, causing erratic, irregular periods, some much heavier than normal Other physical symptoms of the menopausal transition may include: vaginal dryness bladder irritability hot flushes with or without sweats insomnia with or without night sweats Herbal treatment should not be prescribed indefinitely, although it may be required for several years 101 Herbal Strategy Phytoestrogens Support and manage the changing estrogen environment with estrogenic herbs Wild Yam Shatavari Black Cohosh Tribulus Epimedium Kudzu Red Clover 103 © Lee Carroll 2012 102 Phytoestrogens compete strongly for estrogen receptors, however their stimulation of these receptors is much weaker than estradiol Phytoestrogens are selective Can function as estrogen agonists OR antagonists depending on the hormonal milieu Mills S, Bone K. Principles and Practice of Phytotherapy: Modern Herbal Medicine. Churchill Livingston, Edinburgh, 2000, pp 54-56 104 26 SERMs Estrogen Receptor Complexities Estrogen receptors are present in almost all organs of the body There are two main classes of estrogen receptors (ERα and ERβ) which are distributed unevenly in body tissues ERα predominates in the uterus, pituitary, kidney and breast and is the classical estrogen receptor ERβ are found in bone, prostate, brain (hypothalamus) and reproductive organs G protein–coupled receptor (GPER-1) is a recent discovery Selective estrogen receptor modulators Estradiol is a pure estrogen agonist In contrast to pure estrogen agonists or antagonists, SERMs have a mixed or selective pattern of estrogen agonist/antagonist activity, which depends on the tissue targeted and the type of receptor stimulated 105 Phytoestrogens 106 Wild Yam In lower estrogenic environments as in post menopausal women, they provide a net estrogenic effect In a high estrogen environment such as in premenopausal women, their displacement of endogenous (& exogenous) estrogens is thought to have an antiestrogenic effect However, even this net estrogenic effect is subtle, and because of their selective behavior towards the different estrogen receptors they act more like SERMs Menopausal symptoms Spasmodic dysmenorrhea Intestinal colic Diverticulitis Ovarian pain Female infertility Rheumatoid arthritis Mills S, Bone K. Principles and Practice of Phytotherapy: Modern Herbal Medicine. Churchill Livingston, Edinburgh, 2000, pp 54-56 107 © Lee Carroll 2012 108 27 Wild Yam Authenticity of Wild Yam The oral application of Wild Yam (Dioscorea villosa) must be clearly differentiated from its use in “progesterone creams” Steroidal saponins from Wild Yam are not bioavailable through the skin “Progesterone cream” advocates exploit the confusion between the phytochemicals in Wild Yam and progesterone Yams (Dioscorea spp.) are used as a source of precursors in the production of human identical progesterone Many extracts of Wild Yam are sold standardized to diosgenin which is NOT found in the herb and is an indication the herb has been enzymatically degraded during the dried process The predominant steroidal compound in Wild Yam was thought to be dioscin, a steroidal glycoside precursor of diosgenin Research undertaken by MediHerb, has shown that dioscin is only present in small quantities Newly identified compounds methylparvifloside and methylprotodeltonin are the key actives and precursors to diosgenin 109 Is Black Cohosh Estrogenic? Shatavari Black Cohosh is a well known treatment for menopausal symptoms The obvious conclusion to draw is that it has estrogenic properties This has resulted in safety concerns (eg in breast cancer survivors) and over long-term use (eg causing breast cancer) But is Black Cohosh really estrogenic and what does “estrogenic” really mean in the context of plant chemicals? Support for menopausal symptoms Promote general well being by increasing cellular vitality and resistance to stress To improve libido and sexual vitality As a tonic for general debility, fatigue, infections Gastric ulcers and dyspepsia Liver support 111 © Lee Carroll 2012 110 112 28 Is Black Cohosh a SERM? Is Black Cohosh a SERM?? Recent in vivo models generally show a lack of estrogenic effects on reproductive tissues1,2 Positive effects were observed (due to estrogenic effects) in animal models of osteoporosis3,4 There was no growth acceleration in animal models in uterine5 or breast cancer6 1. 2. 3. 4. 5. 6. In general the growth of breast cancer cells in vitro was inhibited1,2 Clinical studies showed amelioration of menopausal symptoms and favorable effects on bone metabolism But with no effect on endometrial thickness and variable effects on vaginal cytology3,4,5 Borrelli F, Izzo AA, Ernst E. Life Sciences 2003; 73(10): 1215-1229 Zhang L, Khan IA, Willett KL et al. J Herb Pharmacother 2003; 3(3): 33-50 Nisslein T, Freudenstein J. J Bone Miner Metab 2003; 21(6): 370-376 Seidlova-Wuttke D, Hesse O, Jarry, H et al. Eur J Endocrinol 2003;149(4): 351-362 Nisslein T, Freudenstein J. Toxicol Lett 2004; 150(3): 271-275 Freudenstein J, Dasenbrock C, Nisslein T. Cancer Res 2002; 62(12): 3448-3452 1. Bodinet C. Freudenstein J. Menopause 2004; 11(3): 281-289 2. Hostanska K, Nisslein T, Freudenstein J et al. Breast Cancer Res Treat 2004; 84(2): 151-160 3. Wuttke W, Seidlova-Wuttke, D, Gorkow C. Maturitas 2003; 44(Suppl 1): S67-S77 4. Hernandez Munoz G, Pluchino S. Maturitas 2003; 44(Suppl 1): S59-S65 5. Liske E, Hanggi W, Henneicke-von Zepelin HH et al. J Womens Health Gend Based Med 2002; 11(2): 163-174 114 113 Tamoxifen Black Cohosh and Tamoxifen 50 breast cancer patients with Tamoxifen treatment 100% patients had surgery, 87% had undergone radiation therapy and approximately 50% had received chemotherapy Every patient was treated with an extract of Black Cohosh (up to 10 mg/day) for 6 months Black Cohosh treatment statistically significantly improved hot flashes, sweating, sleep problems, and anxiety No adverse events, and 90% reported the tolerability of the black cohosh extract as very good or good 115 © Lee Carroll 2012 Rostock M et al. 2011, Black cohosh in tamoxifen-treated breast cancer patients with 116 climacteric complaints - a prospective observational study. Gynecol Endocrinol. Jan 13 29 St John’s Wort Korean Ginseng Four clinical studies have investigated the use of a combination of St John's Wort and Black Cohosh The placebo-controlled trials found the combination to be effective in reducing menopausal symptoms, including the psychological component1-3 The observational study found the combination was superior to Black Cohosh alone in alleviating menopausal mood symptoms4 1 Boblitz N et al. Focus Altern Complement Ther 2000; 5: 85 2 Uebelhack R et al. Obstet Gynecol 2006; 107: 247 3 Chung DJ et al. Yonsei Med J 2007;48: 289 4 Briese V et al. Maturitas 2007; 57: 405 TCM uses include tonification of the vital energy and spleen, calming the nerves, chronic general weakness with irritability and insomnia and organ prolapse In western herbal medicine, Korean Ginseng is used as an adaptogenic tonic indicated for physical or mental exhaustion and depressive states associated with sexual inadequacy 117 Korean Ginseng 119 Sage Clinical trials have reported beneficial results in treating postmenopausal symptoms1 Korean Ginseng improved psychological test scores in postmenopausal women with symptoms of fatigue, insomnia and depression, compared to those without symptoms The improvement was at least partially due to an anti-stress effect, demonstrated by a decrease in the cortisol/DHEA ratio2 Traditionally Salvia officinalis has been used to restrain excessive sweats and for debility of the nervous system including nervous exhaustion1,2 A recent study showed sage extract improved memory and attention and an in-vitro analysis demonstrated the extract had cholinesterase inhibiting properties3 2 1. British Herbal Pharmacopoeia. Bournemouth: BHMA, 1983 1 Frawley D, Lad V. The Yoga of Herbs: An Ayurvedic Guide to Herbal Medicine, 2nd Edn. Lotus Press, Santa Fe, 1988. Briese V et al. Maturitas 2007; 57: 405 2. Felter HW et al. King’s American Dispensatory, 18th Edn, 3rd revision, 1905, reprinted Portland: Eclectic Medical Publications, 1983. 120 © Lee Carroll 2012 3. Scholey AB, etal, Psychopharmacology (Berl). 2008 May;198(1):127-39. Epub 2008 Mar 121 30 Wild Yam Complex Sage Wild Yam root and rhizome 4:1 extract 100 mg from Dioscorea villosa root and rhizome 400 mg A product containing Salvia officinalis and Alfalfa extracts improved menopausal symptoms (hot flashes/flushes, night sweating) in an open trial conducted for 3 months1 Salvia officinalis reduced sweat production in patients with hyperhydrosis (excessive sweating) in a number of open studies2 1 De Leo V et al. Minerva Ginecol 1998; 50: 207 2 ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd Edn. ESCOP, European Scientific Cooperative on Phytotherapy, Exeter, 2003 Shatavari root 4:1 extract from Asparagus racemosus root 400 mg 100 mg St John’s Wort herb flowering top 6:1 extract 100 mg from Hypericum perforatum herb fl top 600 mg Containing hypericins 300 mcg 122 123 Tribulus Wild Yam Complex Sage herb 5:1 extract from Salvia officinalis herb 290 mg 58 mg Black Cohosh root 5:1 extract from Cimicifuga racemosa root 100 mg 20 mg Korean Ginseng root 5:1 extract from Panax ginseng root 75 mg Containing ginsenosides as Rg1 & Rb1 1.3 mg 15 mg Tribulus (Tribulus terrestris) is one of the bestresearched examples of the use of a steroidalsaponin containing herb in menopause Like Wild Yam and Shatavari, Tribulus leaf is rich in steroidal saponins Tribulus leaf is a popular herb in Eastern Europe for the treatment of menopausal symptoms Dosage: 3-4 tablets per day. 6 per day can be used in the first few weeks of treatment to accelerate the effect 124 © Lee Carroll 2012 Stuthe J, et al. Poster presentation: 50th Conference Society of Medicinal Plant Research (GA) in Spain, 2002 125 31 Tribulus Tribulus In an open study, a group of 50 women were first given placebo and then Tribulus leaf extract 52% of patients were experiencing natural menopause, 48% had post-operative symptoms after removal of their ovaries Predominate symptoms included hot flashes (100%), sweating (78%) and insomnia (82%) After active treatment, 98% experienced symptom improvement. No effect was seen for placebo The dosage of leaf extract prescribed varied, but generally a standardized extract corresponding to 200-300 mg of furanosterolic saponins was reached after higher initial doses Treatment did not result in significant changes in FSH, LH, prolactin, estradiol, progesterone and testosterone, although FSH tended to be lower Zarkova S. Tribestan: Experimental and Clinical Investigations. Chemical Pharmaceutical Research Institute, Sofia, Bulgaria. Zarkova S. Tribestan: Experimental and Clinical Investigations. Chemical Pharmaceutical Research Institute, Sofia, Bulgaria. 127 126 Menopause Support Menopause Support Core Support Wild Yam Complex, 3 to 4 tablets per day. Increasing up to 6 tablets with severe symptoms for short periods of time Symplex F, 3 tablets 2 times per day Prolamine Iodine, 1 to 4 tablet per day Additional Support (as required) Tribulus, 3 to 4 tablets per day if hot flashes are still a problem Bone Complex, 1 tablet 3 times daily where low bone mineral density is an issue Additional Support (as required) Chaste Tree, 1 to 3 tablets per day for erratic periods and exaggerated PMS in the perimenopause phase Adrenal Complex, 2 to 3 tablets per day if stress aggravates the hot flashes Thyroid Complex, 3 to 4 tablets per day, for K TSH Drenamin, 3 tablets 2 times per day 128 © Lee Carroll 2012 129 32 Simplified Bowel Flora Protocol Osteoporosis Osteoporosis (OP) is a chronic progressive skeletal disease characterized by: Microarchitecture deterioration Low bone mass As a result the bones become fragile with the increased risk of fracture, especially of the hip, spine & wrist Everyday of the Week Gut Flora Complex, 1 capsule 2 twice daily Wholefood Fibre, 1 tablespoon twice daily at the same time as the Gut Flora Complex As required: Vitanox, 2 to 3 tablets daily ProSynbiotic, 3 capsules daily Lactic Acid Yeast, 1 to 2 wafers 3 times daily Continue for minimum of 6 weeks. Suitable for long term use Sambrook P, Cooper C. Osteoporosis, Lancet 2006; 367(9527): 2010-2018 130 Central Role of Estrogen 131 Central Role of Estrogen Estrogen plays a fundamental role in bone homeostasis in both men & women Osteoblasts, osteocytes & osteoclasts all have estrogen receptors Estrogen deficiency enhances osteoclast formation & prolongs the resorption phase by reducing the apoptotic rate of osteoclasts Thus the balance between withdrawal & deposition is tipped in favor of withdrawal Weitzmann MN, Pacifici R. Estrogen deficiency and bone loss: an inflammatory tale. Journal of Clinical Investigation 2006; 116(5): 1186-1194 Raisz LG. Pathogenesis of Osteoporosis. Journal of Clinical Investigation 2005; 115(12): 3318-3325 132 © Lee Carroll 2012 133 33 Bone Complex Bone Complex Epimedium herb top 12:1 extract from Epimedium sagittatum herb top 2.4 g Containing icariin 20 mg 200 mg Red Clover herb flowering top 5:1 extract from Trifolium pratense herb flowering top 500 mg Containing isoflavones 8 mg 100 mg Kudzu root 10:1 extract from Pueraria lobata root 700 mg Containing puerariae isoflavones calculated as diadzin, puerarin, daidzein 28 mg 70 mg Black Cohosh root 4:1 extract from Cimicifuga racemosa root 80 mg 20 mg Dose: 1 tablet, 3 times daily Indications: Pre-treatment and treatment of osteopenia, (particularly in postmenopausal women) In conjunction with weight-bearing exercise A healthy diet containing food sources of calcium and vitamin D Management of osteoporosis Support and maintain healthy bone density Beneficially influence bone remodelling Support during menopause 134 135 Exercise Exercise, Isoflavones & BMD Exercise is often recommended for increasing BMD, possibly by stimulating estrogen receptors However the increases in BMD are often small with exercise alone But when exercise is combined with isoflavone therapy much larger increases in BMD have been observed Exercise is often recommended for increasing BMD, possibly by stimulating estrogen receptors However the increases in BMD are often small with exercise alone But when exercise is combined with isoflavone therapy much larger increases in BMD and muscle have been observed Chilibeck PD, Cornish SM. Effects of estrogenic compounds (estrogen or phytoestrogens) combined with exercise on bone and muscle mass in older individuals. Appl Physiol Nutr Metab 2008; 33(1): 200-212 136 © Lee Carroll 2012 137 34 Menopausal OP Protocol Bone Complex, 1 tablet 3 times daily Ostrophin PMG, 2 tablets 3 times daily Calcifood powder, 1 to 2 tablespoons per day or Calcifood Wafers, 6 wafers 1 to 2 times per day Cataplex D, 1 tablet 3 times daily Zinc Liver Chelate, 1 tablet 3 times daily Whey Pro Complete and/or Protofood Garlic 5000mg or ChelaCo , 1 tablet 2 to 3 times daily Bowel Flora Protocol yearly Exercise Acknowledgements Special thanks to Associate Professor Kerry Bone for his help with this presentation 138 139 APPENDIX SLIDES Questions? © Lee Carroll 2012 140 35 Pregnancy and Lactation: Some Golden Rules Pregnancy and Lactation A safe and widely-used herb does not suddenly become a dangerous cocktail just because a patient is pregnant Most concerns over herbs in pregnancy and lactation are speculative, unfounded or vastly exaggerated A few simple rules can be followed 1. Only recommend what is truly needed 2. Be particularly cautious in the first trimester 3. Be particularly cautious if there is a history of miscarriage, although the right herbs can help to avoid this 4. Avoid toxic herbs 5. Be careful of laxative herbs 6. Refer to the resources mentioned 7. If it is contraindicated in the catalog – don’t use it! Menorrhagia Menorrhagia - Common Causes Abnormally heavy period with a normal cycle length Most causes are functional: nothing essentially wrong but there is abnormality in function Need to know the cause before treating Hypothalmic Pituitary unit The ovary Excessive stimulation of the endometrium by estrogen Failure to produce progesterone Imbalance in prostaglandin levels Hypothyroidism, low Iron stores, clotting dysfunction Uterine tone, infections and fibroids 144 © Lee Carroll 2012 Functional Uterine Fibroids and Polyps Endometriosis Pelvic Inflammatory Disease (PID) Contraceptive causes Non-Gynecological causes Pregnancy 145 36 Functional Menorrhagia Functional Menorrhagia May reflect an excessive estrogen to progesterone ratio accompanied by prostaglandin imbalance Saturated fat intake may be too high. May be complicated by fibroids, endometriosis or infection Check iron status Chaste Tree is a Key Herb An improvement was reported in 66% of patients with heavy or frequent bleeding (uncontrolled trial) For 58 cases of menorrhagia, average duration of bleeding decreased from 8 to 5 days (uncontrolled trial) Doses may need to be higher than for PMS - up to 5 tablets per day or 5 mL of 1:2, throughout the cycle 146 Functional Menorrhagia Protocol for Functional Menorrhagia Capsella Complex Phytosynergist This combines well with Chaste Tree Shepherd’s Purse is antihemorrhagic one of the best Dong Quai is a general female tonic and False Unicorn is a uterine tonic White Peony to correct hormonal imbalance Can be taken throughout the cycle with increased doses during menstruation Core Support Capsella Complex Phytosynergist, 5 mL 3 times per day during the cycle FemCo, 3 tablets per day Additional Support Fe-Max Iron Tonic: 5 mL twice a day To replenish iron reserves if they are low Chaste Tree, 3 to 6 tablets per day 148 © Lee Carroll 2012 147 149 37 Amenorrhea and Oligomenorrhea Amenorrhea is the absence of the period Amenorrhea is divided into primary and secondary Primary: menstruation has not commenced by the age of seventeen or within 2 years of physical maturation Secondary is a cessation for 6 months or more or for more than 3 cycles when the cycles are longer than normal Oligomenorrhea is menstruation that is markedly diminished Secondary Amenorrhea Common causes Uterine causes eg obstruction or endometrial tissue destruction Hypothalamic Stress Weight loss Rigorous exercise Severe chronic illness Post - Pill amenorrhea 150 Secondary Amenorrhea Protocol Secondary Amenorrhea Pituitary Pituitary insufficiency Failure to ovulate PCOS (see PCOS) Breastfeeding Thyroid conditions Cushings syndrome Core Support Chaste Tree: 2 tablets 2 to 3 times daily Reduce hyperprolactinaemia Tribulus 1 tablet 3 times daily every day Once period starts switch to 1 tablet 3 times daily on days 5 to 14 of the menstrual cycle (or to ovulation) FemCo: 1 tablets 3 to 2 times daily throughout cycle Assists with hormone balance 152 © Lee Carroll 2012 151 153 38 Protocol Secondary Amenorrhea Endometriosis Additional Support Dong Quai, 1 tablet 2 to 3 times daily Has been traditionally for amenorrhea Ovex, 6 tablets per day Symplex F, 6 tablets per day Cataplex E, 6 tablets per day Endometriosis is a chronic inflammatory disease, characterised by implantation and growth of endometrial tissue outside the uterine cavity In most cases lesions are found in the peritoneal cavity but can occur anywhere in the body It is one of the most frequent diseases in gynaecology, affecting 15-20% of women in their reproductive life Matarese G, De Placido G et al. Trends Mol Med 2003; 9(5): 223-228 154 155 Endometriosis Endometriosis The pathophysiology of endometriosis still remains unclear1 The retrograde menstruation theory has been widely accepted, however retrograde menstruation occurs in most women of reproductive age, so there must be other factors at play There is substantial evidence linking alterations in both cell-mediated and humoral immunity with the pathogenesis of endometriosis2 1. Hull Ml, Escareno Cr et al. am J Pathol 2008; 173(3): 700-715 2. Ulukus M, Arici A. Minerva Ginecol 2005; 57(3): 237-24 © Lee Carroll 2012 It is associated with increased secretion of pro-inflammatory cytokines, intrinsic anomalies of the refluxed endometrium and impaired immune function1 Genetic predisposition, environmental factors and alterations in immune and endocrine functions are believed to play significant roles in the establishment and maintenance of endometriosis2 156 1. Matarese G, De Placido G et al. Trends Mol Med 2003; 9(5): 223-228 2. Ulukus M, Cakmak H, Arici A. J Soc Gynecol Investig 2006; 13(7): 467-476 157 39 Endometriosis Endometriosis Symptoms Endometriosis has been considered to be an autoimmune disease because it is often associated with the presence of autoantibodies and other autoimmune diseases1 In one study anti-endometrial antibodies were detected in 60% of endometriosis patients These autoantibodies may be partially responsible for the frequency of miscarriage/poor implantation associated with this condition2 Dysmenorrhoea Pelvic pain and cramping may begin before and extend several days into menstruation and may include lower back and abdominal pain, nausea and diarrhoea Pain at other times Pelvic pain during ovulation Sharp pain deep in the pelvis during intercourse Pain during bowel movements or urination Ulukus M, Arici A. Minerva Ginecol 2005; 57(3): 237-24 Gajbhiye R, Survawanshi A et al. Reprod Biomed Online 2008; 16(6): 817-824 158 159 Endometriosis Treatment Endometriosis Symptoms Alleviate symptoms eg dysmenorrhea Reduce inflammation Modulate immunity Regulate hormones Support liver to eliminate toxins and excessive estrogen Aim to prevent/treat complications eg scarring Excessive bleeding Occasional heavy periods (menorrhagia) Bleeding between periods (menometrorrhagia) Spotting during the cycle is a common sign of endometriosis Infertility Endometriosis is often first diagnosed in women who are seeking treatment for infertility 160 © Lee Carroll 2012 161 40 Protocol for Endometriosis Core Treatment Chaste Tree: 2 tablets 2 to 3 times daily Reduce estrogen dominance Echinacea Premium: 1 tablet 2 to 3 times daily Modulate immunity and increase NK cells LivCo: 1 tablet 3 times daily Aid elimination of excessive hormones & toxins FemCo: 1 tablets 3 to 2 times daily throughout cycle Dong Quai: 1 tablets 3 times daily As a uterine tonic and to regulate menstruation. Use up to ovulation and not during heavy bleeding Protocol for Endometriosis 162 Pharmacokinetics 163 Pharmacokinetics Intestinal metabolism of isoflavones to their aglycone forms is crucial for ensuring bioavailability & therapeutic activity The health of intestinal microflora is pivotal in the healthy metabolism of estrogenic phytochemicals Individual differences in intestinal microflora have been proposed as a possible reason why there is some inconsistency in the clinical effects of phytoestrogens The bioavailability of phytoestrogens & isoflavones in particular is dependant on a number of factors Isoflavones are present in plants & plant extracts as glycosides (sugar + aglycone) and are inactive in this form The active principles are derived from the aglycone component The GIT needs to hydrolyse the bond between the sugar & aglycone via intestinal glucosidase enzymes Vatanparast H, Chilibeck PD. Does the Effect of Soy Phytoestrogens on Bone in Postmenopausal Women Depend on the Equol-Producing Phenotype? Nutr Rev 2007; 65(6): 294-299 164 © Lee Carroll 2012 Additional Support Boswellia Complex: 1 to 2 tablets 3 times daily Reduce inflammation and exert antioxidant activity Rehmannia Complex: 1 tablet 3 times daily Reduce autoantibodies and inflammation Gotu Kola Complex: 1 tablet 3 times daily To promote healing and reduce scarring Cramplex: 2 tablets 2 to 3 times daily For dysmenorrhea Capsella Complex: 5 mL 2 to 4 times per day For associated heavy menstrual bleeding 165 41 Gut Metabolism of Isoflavones & Steroidal Saponins Turner NJ, Thomson BM, Shaw IC. Bioactive Isoflavones in Functional Foods: The Importance of Gut Microflora on Bioavailability. Nutr Rev 2003; 61(6): 204-213 Gut Metabolism of Diadzin The best studied example of this is the isoflavone diadzin Diadzin is reduced to the aglycone diadzein by enzymes (glucosidases) produced by the gut microflora Diadzein is then subjected to further reduction as a result of the action of the gut microflora to produce equol, which is the active estrogenic compound Vatanparast H, Chilibeck PD. Does the Effect of Soy Phytoestrogens on Bone in Postmenopausal Women Depend on the Equol-Producing Phenotype? Nutr Rev 2007; 65(6): 294-299 166 Non-responders to Isoflavones 167 Non-responders to Isoflavones Oral antibiotics are known to reduce equol production1 Numerous clinical experiences in treating women with menopausal symptoms with herbal extracts containing isoflavones have demonstrated that a gut flora balancing protocol is beneficial in bringing about a therapeutic effect in those clients that do not respond initially This provides the rationale for the gut flora protocol for non-responders There are large individual variances in the capacity to produce equol (up to 400 fold) & hence a therapeutic effect Dietary fat consumption is known to reduce this capacity1 Dietary supplementation with fructooligosaccharides such as inulin are known to increase the capacity to produce equol2 1. Rowland IR, Wiseman H, Sanders TAB. Interindividual Variations in Metabolism of Soy Isoflavones and Lignans: Influence of Habitual Diet on Equol Production by the Gut Microflora. Nutr Cancer 2000; 36(1): 27-32 1. Halm BM, Franke AA, Ashburn LA et al. Oral antibiotics decrease urinary isoflavonoid excretion in children after soy consumption. Nutr Cancer 2008; 60(1): 14-22 2. Tokunaga T. Novel physiological functions of fructooligosaccharides. Biofactors 2004; 21(1-4): 89-94 168 © Lee Carroll 2012 169 42 Epimedium: Clinical Trial Epimedium Epimedium-derived icariin and isoflavones demonstrated beneficial effects in late postmenopausal women, without resulting in a detectable hyperplasia effect on the endometrium 24-month randomized double-blind placebo-controlled clinical trial 100 postmenopausal women with lumbar spine BMD, with T scores of between -2 & -2.5 Licentious Goat Wort or Horny Goat weed A TCM herb that tonifies the kidneys & fortifies the yang. Actions which strengthen bones Indicated for weak limbs Epimedium contains a unique flavonoid icariin, along with the isoflavones genistein and daidzein Many OP experimental studies have been conducted on either the herb or Icariin Zhang G, Qin L, Shi Y. Epimedium-derived phytoestrogen flavonoids exert beneficial effect on preventing bone loss in late menopausal women: a 24-month randomized, doubleblind and placebo controlled trial. J Bone Miner Res 2007; 22(7): 1072-1079 Bensky D, Gamble A. Chinese Herbal Medicine: Materia Medica. Eastland Press, Seattle, 1993, pp 341-342 170 171 Epimedium: Clinical Trial Epimedium: Clinical Trial Active group (n=50) received a daily dose of Epimedium extract containing 60 mg icariin, 15 mg diadzein and 3 mg genistein Placebo group (n=50) Both groups received 300 mg of calcium as citrate daily Epimedium significantly ↓ levels of deoxypyridinoline at 12 months (43% p=0.000) and 24 months (39% p=0.000), with no change in the placebo group Osteocalcin increased 5.6% (p=0.530) at 12 months and 10.7% (p=0.267) at 24 months. No change in placebo group Serum estradiol, no change in the Epimedium group Zhang G, Qin L, Shi Y. J Bone Miner Res 2007; 22(7): 1072-1079 Zhang G, Qin L, Shi Y. J Bone Miner Res 2007; 22(7): 1072-1079 172 © Lee Carroll 2012 173 43 Epimedium: Clinical Trial Epimedium: Clinical Trial BMD (lumbar spine) treatment group ↑ 1.0% at 12 months ↑ 1.3% at 24 months BMD (lumbar spine) placebo group ↓ 1.7% at 12 months ↓ 2.4% at 24 months Difference b/w placebo at 12 months p = 0.044 Difference b/w placebo 24 months p = 0.006 BMD (femoral neck) treatment group ↑ 1.1% at 12 months ↑ 1.6% at 24 months BMD (femoral neck) placebo group ↓ 1.4% at 12 months ↓ 1.8% at 24 months Difference b/w placebo 12 months p = 0.061 Difference b/w placebo 24 months p = 0.008 Zhang G, Qin L, Shi Y. J Bone Miner Res 2007; 22(7): 1072-1079 Zhang G, Qin L, Shi Y. J Bone Miner Res 2007; 22(7): 1072-1079 174 © Lee Carroll 2012 175 44